Cite
Ochiai T, Nishimura K, Watanabe T, et al. Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test. Oncol Lett. 2017;14(5):6045-6052doi: 10.3892/ol.2017.6960.
Ochiai, T., Nishimura, K., Watanabe, T., Kitajima, M., Nakatani, A., Nagayasu, K., Naito, S., Sato, T., Kishine, K., Abe, Y., Hara, C., Yamada, S., Mashiko, S., & Nagaoka, I. (2017). Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test. Oncology letters, 14(5), 6045-6052. https://doi.org/10.3892/ol.2017.6960
Ochiai, Takumi, et al. "Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test." Oncology letters vol. 14,5 (2017): 6045-6052. doi: https://doi.org/10.3892/ol.2017.6960
Ochiai T, Nishimura K, Watanabe T, Kitajima M, Nakatani A, Nagayasu K, Naito S, Sato T, Kishine K, Abe Y, Hara C, Yamada S, Mashiko S, Nagaoka I. Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test. Oncol Lett. 2017 Nov;14(5):6045-6052. doi: 10.3892/ol.2017.6960. Epub 2017 Sep 15. PMID: 29113244; PMCID: PMC5661441.
Copy
Download .nbib